Cerenome (PSTV) Change in Receivables (2010 - 2020)
Plus Therapeutics (PSTV) posted quarterly Change in Receivables of -$951000.0 for Q3 2020, down 119.72% year-over-year from $4.8 million in Q4 2019, and down 3422.22% quarter-over-quarter from -$27000.0 in Q2 2020.
Cerenome (PSTV) Change in Receivables (2010 - 2020) Analysis & Trends
Plus Therapeutics (PSTV) has reported Change in Receivables for 11 consecutive years, with -$951000.0 the latest figure, recorded in Q3 2020.
- In Q3 2020, Change in Receivables fell 119.72% year-over-year to -$951000.0; the TTM figure through Jun 2021 stood at -$951000.0 (down 199.37% YoY), while the FY2020 annual figure was -$1.2 million, down 197.17% from the prior year.
- Change in Receivables declined to -$951000.0 in Q3 2020 per PSTV's latest filing, from -$27000.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $4.8 million in Q3 2019 and bottomed at -$3.6 million in Q4 2019.
- Historically, Change in Receivables has averaged -$39105.3 across 5 years, with a median of -$138000.0 in 2017.
- On a YoY basis, Change in Receivables climbed as much as 11383.33% in 2019 and fell as far as 2451.05% in 2019.
- Plus Therapeutics' Change in Receivables stood at $270000.0 in 2016, then sank by 151.11% to -$138000.0 in 2017, then declined by 3.62% to -$143000.0 in 2018, then sank by 2451.05% to -$3.6 million in 2019, then jumped by 73.93% to -$951000.0 in 2020.
- Business Quant data shows PSTV's Change in Receivables at -$951000.0 in Q3 2020, -$27000.0 in Q2 2020, and -$191000.0 in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -951,000.00 |
| Sep 30, 2020 | -951,000.00 |
| Jun 30, 2020 | -27,000.00 |
| Jun 30, 2020 | -27,000.00 |
| Mar 31, 2020 | -191,000.00 |
| Mar 31, 2020 | -191,000.00 |
| Dec 31, 2019 | -3.65 Mn |
| Dec 31, 2019 | -3.65 Mn |
| Sep 30, 2019 | 4.82 Mn |
| Sep 30, 2019 | 4.82 Mn |
| Jun 30, 2019 | -184,000.00 |
| Jun 30, 2019 | -184,000.00 |
| Mar 31, 2019 | 212,000.00 |
| Mar 31, 2019 | 212,000.00 |
| Dec 31, 2018 | -143,000.00 |
| Dec 31, 2018 | -143,000.00 |
| Sep 30, 2018 | 42,000.00 |
| Sep 30, 2018 | 42,000.00 |
| Jun 30, 2018 | -473,000.00 |
| Jun 30, 2018 | -473,000.00 |